RainDance Technologies Appoints McNary President and CEO

    GUILFORD, Conn., Nov. 28 /PRNewswire/ -- RainDance Technologies, Inc.,
 a developer of NanoReactor droplet-based microfluidic technology, today
 announced the appointment of Christopher McNary as President and Chief
 Executive Officer. McNary will join Jonathan Rothberg, Chairman of the
 Board, in driving RainDance Technologies' vision and the upcoming
 commercial launch of its Professional Laboratory System in the Life
 Sciences and other related markets.
 
     "Mr. McNary joins an outstanding leadership team that includes a
 distinguished Scientific Advisory Board with three Nobel Prize recipients
 and a Board of Directors with the former Presidents of Applied Biosystems
 and Affymetrix, plus an experienced Partner from Mohr Davidow Ventures,"
 said Rothberg. "He will assist us in attracting additional talent to
 develop first-rate manufacturing and customer support capabilities and to
 commercially launch our exciting new products and applications."
 
     The RainDance Professional Laboratory System combines microdroplets and
 microfluidics to enable a host of nanoscale cell-based and molecular
 assays. Samples (cells, beads, DNA templates, chemical compounds) and
 reactants are encapsulated in individual micron-sized droplets on
 assay-specific NanoReactor chips. With each droplet being the equivalent of
 a well in a microtiter plate, the Professional Laboratory System can
 process and analyze 10,000 samples per second with unparalleled accuracy.
 The precise manipulation of minute amounts of fluids within NanoReactor
 droplets will benefit a variety of industrial and research applications,
 including DNA sequencing preparation, enzyme engineering, functional cell
 sorting, multiplex PCR, SNP detection, gene expression, and RNAi functional
 assays.
 
     "Our Professional Laboratory System is game-changing technology that
 has attracted a tremendous level of market interest," said Darren Link,
 Senior Vice President of Research and Development and RainDance
 Technologies founder. "Mr. McNary's depth of expertise and proven
 leadership in the commercialization of life science tools will be
 instrumental in guiding our company's growth. I look forward to working
 with him and our visionary Board of Directors to transform the future of
 laboratory practices," he said.
 
     Mr. McNary has more than 25 years of experience in Life Sciences and
 Diagnostic markets with 14 years in senior management positions. He joins
 RainDance from Thermo Fisher Scientific where he was Vice President and
 General Manager. He also has served as President and CEO of early-stage
 start-up companies and held executive management positions at Chiron
 Diagnostics and Tecan.
 
     "RainDance has built an impressive management team supported by a
 Scientific Advisory and Board of Directors with the proven experience in
 commercializing innovative technology platforms such as the Professional
 Laboratory System," said McNary. "This team and platform are well
 positioned to realize the full benefits of microfluidics in a variety of
 markets and applications."
 
     About RainDance Technologies, Inc.
 
     RainDance Technologies, Inc. is a nanotechnology company devoted to
 developing and commercializing the Professional Laboratory System, a
 platform for droplet-based microfluidics. The Professional Laboratory
 System is an integrated fluid handling system that provides precise
 manipulation of minute amounts of fluids for a variety of industrial and
 research applications within genomic, drug discovery, industrial enzyme
 development, and molecular diagnostic markets. At the core of the system's
 power are assay-specific NanoReactor chips composed of fluid handling
 modules that encapsulate samples and reactants in individual micron-sized
 droplets. Founded in 2004 by scientists from Harvard University, the
 Medical Research Centre in Cambridge, and the ESPCI in Paris, RainDance
 Technologies designed the Professional Laboratory System to be the chemical
 equivalent of a personal computer. As a computer manipulates bits of
 information, the system's NanoReactor technology enables the programmable
 handling of cells and fluid samples for innovative assay and screening
 applications. The promise of this technology has attracted an outstanding
 Scientific Advisory Board, including three Nobel Prize winners (Jean-Marie
 Lehn, Sir Aaron Klug, and Dr. Richard Roberts) and Sir Gregory Winter. For
 more information, please visit http://www.raindancetechnologies.com.
 
 
 

SOURCE RainDance Technologies, Inc.